We examined the inhibitional and nutritional effects of total parenteral nutrition ( The protein content in the liver tissues of these two groups was significantly higher as compared with the control group. The DNA content in the liver tissue was also significantly higher in the D-Met group. The body weight including the tumor (on the final day of TPN) was significantly lower in the D-Val group as compared with the control group, but there was no significant difference in the groups for body weights not including tumors (carcass body weight). The hematocrit and hemoglobin values, indicators of anemia, were significantly higher in the D-Val group as compared with the control group. From these results, regarding tumor growth inhibition, the D-Val solution had the strongest inhibitory effect with no negative influence on the host, and improvement of nutritional status was also suggested in the rats that received the D-Leu or D-Met solutions.
In the D-Val group, decreases of DNA and protein contents in the tumor tissues were also observed. The D-Leu and D-Met groups showed a tendency toward tumor growth inhibition. The protein content in the liver tissues of these two groups was significantly higher as compared with the control group. The DNA content in the liver tissue was also significantly higher in the D-Met group. The body weight including the tumor (on the final day of TPN) was significantly lower in the D-Val group as compared with the control group, but there was no significant difference in the groups for body weights not including tumors (carcass body weight). The hematocrit and hemoglobin values, indicators of anemia, were significantly higher in the D-Val group as compared with the control group. From these results, regarding tumor growth inhibition, the D-Val solution had the strongest inhibitory effect with no negative influence on the host, and improvement of nutritional status was also suggested in the rats that received the D-Leu or D-Met solutions. Key Words D-amino acid, tumor growth inhibition, nutritional support, total parenteral nutrition, rat
The use of total parenteral nutrition (TPN) treatment has spread rapidly since Dudrick first described the TPN method in 1968 (1) . TPN is now a supportive therapy commonly used for cancer patients. However, several animal studies have suggested that TPN may prompt tumor growth (2) (3) (4) . Some investigators obtained a decrease in tumor growth in animal models using a special amino acids solution for TPN. Amino acid TPN preparations deprived of methionine (5) (6) (7) (8) , valine (9, 10) or tryptophan (11) produced tumor growth inhibition , but also had negative influences on the host animals (12, 13) .
Naylor et al reported that, in their in vitro study , D-amino acids were utilized in normal tissue and not utilized in tumor tissue (14) because D-amino acid oxidase , a key enzyme for D-amino acid utilization, was not present in the tumor tissue .
We suspected that D-amino acids could be the material of an amino acid solution that could inhibit tumor growth without negatively affecting the host . There are no previous reports of a D-amino acid solution being infused to animals as a study of tumor growth and nutritional status . In this study, we selected four D-amino acids (D-Phe, D-Val, D-Leu and D-Met) that can be converted into L-amino acid in normal tissue (14, 15) and infused them into AH 109A hepatoma -bearing rats by TPN. This is the first study using animals to investigate the tumor growth inhibition and nutritional effects of total parenteral nutrition containing D-amino acids. 
RESULTS

Tumor volume and tumor weight
The tumor growth of each group is shown in Fig. 1 . On day 7 of TPN , the tumor growth in the D-Val group was significantly lower than that in the control group. Though there was no significant difference, the tumor growth in the D-Leu and D-Met groups also tended to be lower than that in the control group . The tumor weights of each group are shown in Fig. 2 . The tumor weight was significantly lower in the D-Val group. The same tendency was observed in the D-Leu and D-Met groups, but no significant difference was observed.
Body and organ weights
The body and organ weights (liver, gastrocnemius muscle , epididymal fat pad) after the end of TPN are shown in Table 2 . Body weights including the tumor were significantly lower in the D-Val group than in the control group , but there was no significant difference among the groups for body weight not including the tumor (carcass body weight). The liver weight was significantly lower in the D-Leu and D-Met groups as compared with the control group . There was no significant difference among the groups for gastrocnemius muscle and epididymal fat pad weights, which are parameters used for nutritional assessment . Table 3 . The Ht and Hb were significantly higher in the D-Val group as compared with the control group. Though there was no significant difference, these values tended to be high in the D-Met group. There was no significant difference in RBC value among the groups, but the D-Val and D-Met groups tended to have high RBC values.
Protein and nucleic acid contents in liver and tumor tissues
The protein and nucleic acid (DNA and RNA) contents in the livers and tumors are shown in Table 4 
DISCUSSION
Most patients receiving TPN are cancer patients . Cancer cachexia is a symptom of cancer (20) (21) (22) , as is protein malnutrition (23) (24) (25) . To counteract protein mal nutrition, several infusion solutions for cancer patients have been studied . Some of these studies focused on the amino acid imbalance produced by the parenteral administration of an infusion solution depleted of a specific amino acid in order to inhibit tumor growth (5) (6) (7) (8) (9) (10) (11) , and found that the imbalance can have a detrimental the organism was considered. The difference in the size of the amino acid pool might have been greatly influenced during the 7-d TPN period. Furthermore, the difference of effect might have been influenced by the kind of tumor cell . The Ht, Hb and RBC values, indicators of anemia , were significantly higher in the D-Val group. Anemia of malignancy is common in cancer patients (29 , 30) . D-Val-supplemented TPN has been demonstrated to be more effective than L-Val-supplemented TPN for improving malignancy anemia.
In conclusion, our results suggest that D-amino acid solutions can improve the nutritional status of the host and inhibit tumor growth, and that a solution containing D-Val could be used as an amino acid solution for cancer patients . As for other D-amino acids, there is a possibility that they could be useful for the nutritional support of cancer patients, but further studies using animal models are necessary to clarify the optimal use of D-amino acids for TPN.
